globenewswire.com

Tango Therapeutics Executive Chair Barbara Weber Steps Down

Tango Therapeutics logoTango Therapeutics
Sig1.80Sen+1.40Env0.00Soc0.00Gov-0.80

Tango Therapeutics, a clinical-stage biotech focused on precision cancer medicines using synthetic lethality, announced that Dr. Barbara Weber, Executive Chairman of its Board, will step down due to other pursuits. Dr. Weber said she is proud of progress and confident the company is well positioned to build on its achievements. President Dr. Malte Peters thanked her for vision, leadership, and commitment to employees and the company’s work.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro